ALQGC.PA · Quantum Genomics Société Anonyme

-

Please sign in to comment on ALQGC.PA

1 Comment

Admin

4 years ago

Quantum Genomics Société Anonyme is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.

From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.2.

Finally, its free cash flow fell by 43.8% to $-3M since the same quarter in the previous year.

Based on the above factors, Quantum Genomics Société Anonyme gets an overall score of 1/5.

Exchange	PA
CurrencyCode	EUR
Sector	Healthcare
Industry	Biotechnology
ISIN	FR0011648971

Market Cap	5M
PE Ratio	None
Target Price	10
Beta	0.43
Dividend Yield	None

ABOUT

Quantum Genomics Société Anonyme

Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

ALQGC.PA · Quantum Genomics Société Anonyme

-

Quantum Genomics Société Anonyme

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Quantum Genomics Société Anonyme using a moving average strategy